The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis

Laura J. Balcer, Lisanne J. Balk, Alexander U. Brandt, Peter Calabresi, Elena H. Martinez-Lapiscina, Rachel C. Nolan, Friedemann Paul, Axel Petzold, Shiv Saidha

Research output: Contribution to journalArticle

Abstract

BACKGROUND: The International Multiple Sclerosis Visual System Consortium (IMSVISUAL) was formed in November 2014 with the primary goal of improving research, care, and education regarding the role of the visual system in multiple sclerosis (MS) and related disorders. METHODS: In this review, we describe the formation, goals, activities, and structure of IMSVISUAL, as well as the relationship of IMSVISUAL with the Americas Committee for Treatment and Research in MS (ACTRIMS). Finally, we provide an overview of the work IMSVISUAL has completed to date, as well as an outline of research projects ongoing under the auspices of IMSVISUAL. RESULTS: IMSVISUAL has 140 members worldwide and continues to grow. Through IMSVISUAL-related research, optical coherence tomography (OCT)-derived peripapillary retinal nerve fiber layer (pRNFL) thinning has been established as a predictor of future disability in MS. IMSVISUAL has also developed guidelines for reporting OCT studies in MS. Moreover, a systematic review performed by IMSVISUAL found that not only are pRNFL and ganglion cell + inner plexiform layer (GCIPL) thicknesses reduced in patients with MS (particularly in eyes with prior optic neuritis [ON]), but that inner nuclear layer measures may be higher among MS ON eyes, relative to healthy control eyes. Currently, there are several ongoing IMSVISUAL projects that will establish a role for visual outcomes in diagnosing MS and quantifying the effects of emerging therapies in clinical trials. CONCLUSIONS: The development of IMSVISUAL represents a major collaborative commitment to defining the role of visual outcomes in high-quality, large-scale studies that generate definitive and instructive findings in the field of MS. As a consortium, IMSVISUAL has completed several international collaborative projects, is actively engaged in numerous ongoing research studies, and is committed to expanding the role of vision research in MS and related disorders.

Original languageEnglish (US)
Pages (from-to)494-501
Number of pages8
JournalJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Volume38
Issue number4
DOIs
StatePublished - Dec 1 2018

Fingerprint

Multiple Sclerosis
Research
Optic Neuritis
Optical Coherence Tomography
Nerve Fibers
Ganglia

ASJC Scopus subject areas

  • Ophthalmology
  • Clinical Neurology

Cite this

The International Multiple Sclerosis Visual System Consortium : Advancing Visual System Research in Multiple Sclerosis. / Balcer, Laura J.; Balk, Lisanne J.; Brandt, Alexander U.; Calabresi, Peter; Martinez-Lapiscina, Elena H.; Nolan, Rachel C.; Paul, Friedemann; Petzold, Axel; Saidha, Shiv.

In: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, Vol. 38, No. 4, 01.12.2018, p. 494-501.

Research output: Contribution to journalArticle

Balcer, Laura J. ; Balk, Lisanne J. ; Brandt, Alexander U. ; Calabresi, Peter ; Martinez-Lapiscina, Elena H. ; Nolan, Rachel C. ; Paul, Friedemann ; Petzold, Axel ; Saidha, Shiv. / The International Multiple Sclerosis Visual System Consortium : Advancing Visual System Research in Multiple Sclerosis. In: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2018 ; Vol. 38, No. 4. pp. 494-501.
@article{a360abe2ffee45a3800467a637f87d38,
title = "The International Multiple Sclerosis Visual System Consortium: Advancing Visual System Research in Multiple Sclerosis",
abstract = "BACKGROUND: The International Multiple Sclerosis Visual System Consortium (IMSVISUAL) was formed in November 2014 with the primary goal of improving research, care, and education regarding the role of the visual system in multiple sclerosis (MS) and related disorders. METHODS: In this review, we describe the formation, goals, activities, and structure of IMSVISUAL, as well as the relationship of IMSVISUAL with the Americas Committee for Treatment and Research in MS (ACTRIMS). Finally, we provide an overview of the work IMSVISUAL has completed to date, as well as an outline of research projects ongoing under the auspices of IMSVISUAL. RESULTS: IMSVISUAL has 140 members worldwide and continues to grow. Through IMSVISUAL-related research, optical coherence tomography (OCT)-derived peripapillary retinal nerve fiber layer (pRNFL) thinning has been established as a predictor of future disability in MS. IMSVISUAL has also developed guidelines for reporting OCT studies in MS. Moreover, a systematic review performed by IMSVISUAL found that not only are pRNFL and ganglion cell + inner plexiform layer (GCIPL) thicknesses reduced in patients with MS (particularly in eyes with prior optic neuritis [ON]), but that inner nuclear layer measures may be higher among MS ON eyes, relative to healthy control eyes. Currently, there are several ongoing IMSVISUAL projects that will establish a role for visual outcomes in diagnosing MS and quantifying the effects of emerging therapies in clinical trials. CONCLUSIONS: The development of IMSVISUAL represents a major collaborative commitment to defining the role of visual outcomes in high-quality, large-scale studies that generate definitive and instructive findings in the field of MS. As a consortium, IMSVISUAL has completed several international collaborative projects, is actively engaged in numerous ongoing research studies, and is committed to expanding the role of vision research in MS and related disorders.",
author = "Balcer, {Laura J.} and Balk, {Lisanne J.} and Brandt, {Alexander U.} and Peter Calabresi and Martinez-Lapiscina, {Elena H.} and Nolan, {Rachel C.} and Friedemann Paul and Axel Petzold and Shiv Saidha",
year = "2018",
month = "12",
day = "1",
doi = "10.1097/WNO.0000000000000732",
language = "English (US)",
volume = "38",
pages = "494--501",
journal = "Journal of Neuro-Ophthalmology",
issn = "1070-8022",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The International Multiple Sclerosis Visual System Consortium

T2 - Advancing Visual System Research in Multiple Sclerosis

AU - Balcer, Laura J.

AU - Balk, Lisanne J.

AU - Brandt, Alexander U.

AU - Calabresi, Peter

AU - Martinez-Lapiscina, Elena H.

AU - Nolan, Rachel C.

AU - Paul, Friedemann

AU - Petzold, Axel

AU - Saidha, Shiv

PY - 2018/12/1

Y1 - 2018/12/1

N2 - BACKGROUND: The International Multiple Sclerosis Visual System Consortium (IMSVISUAL) was formed in November 2014 with the primary goal of improving research, care, and education regarding the role of the visual system in multiple sclerosis (MS) and related disorders. METHODS: In this review, we describe the formation, goals, activities, and structure of IMSVISUAL, as well as the relationship of IMSVISUAL with the Americas Committee for Treatment and Research in MS (ACTRIMS). Finally, we provide an overview of the work IMSVISUAL has completed to date, as well as an outline of research projects ongoing under the auspices of IMSVISUAL. RESULTS: IMSVISUAL has 140 members worldwide and continues to grow. Through IMSVISUAL-related research, optical coherence tomography (OCT)-derived peripapillary retinal nerve fiber layer (pRNFL) thinning has been established as a predictor of future disability in MS. IMSVISUAL has also developed guidelines for reporting OCT studies in MS. Moreover, a systematic review performed by IMSVISUAL found that not only are pRNFL and ganglion cell + inner plexiform layer (GCIPL) thicknesses reduced in patients with MS (particularly in eyes with prior optic neuritis [ON]), but that inner nuclear layer measures may be higher among MS ON eyes, relative to healthy control eyes. Currently, there are several ongoing IMSVISUAL projects that will establish a role for visual outcomes in diagnosing MS and quantifying the effects of emerging therapies in clinical trials. CONCLUSIONS: The development of IMSVISUAL represents a major collaborative commitment to defining the role of visual outcomes in high-quality, large-scale studies that generate definitive and instructive findings in the field of MS. As a consortium, IMSVISUAL has completed several international collaborative projects, is actively engaged in numerous ongoing research studies, and is committed to expanding the role of vision research in MS and related disorders.

AB - BACKGROUND: The International Multiple Sclerosis Visual System Consortium (IMSVISUAL) was formed in November 2014 with the primary goal of improving research, care, and education regarding the role of the visual system in multiple sclerosis (MS) and related disorders. METHODS: In this review, we describe the formation, goals, activities, and structure of IMSVISUAL, as well as the relationship of IMSVISUAL with the Americas Committee for Treatment and Research in MS (ACTRIMS). Finally, we provide an overview of the work IMSVISUAL has completed to date, as well as an outline of research projects ongoing under the auspices of IMSVISUAL. RESULTS: IMSVISUAL has 140 members worldwide and continues to grow. Through IMSVISUAL-related research, optical coherence tomography (OCT)-derived peripapillary retinal nerve fiber layer (pRNFL) thinning has been established as a predictor of future disability in MS. IMSVISUAL has also developed guidelines for reporting OCT studies in MS. Moreover, a systematic review performed by IMSVISUAL found that not only are pRNFL and ganglion cell + inner plexiform layer (GCIPL) thicknesses reduced in patients with MS (particularly in eyes with prior optic neuritis [ON]), but that inner nuclear layer measures may be higher among MS ON eyes, relative to healthy control eyes. Currently, there are several ongoing IMSVISUAL projects that will establish a role for visual outcomes in diagnosing MS and quantifying the effects of emerging therapies in clinical trials. CONCLUSIONS: The development of IMSVISUAL represents a major collaborative commitment to defining the role of visual outcomes in high-quality, large-scale studies that generate definitive and instructive findings in the field of MS. As a consortium, IMSVISUAL has completed several international collaborative projects, is actively engaged in numerous ongoing research studies, and is committed to expanding the role of vision research in MS and related disorders.

UR - http://www.scopus.com/inward/record.url?scp=85056301729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056301729&partnerID=8YFLogxK

U2 - 10.1097/WNO.0000000000000732

DO - 10.1097/WNO.0000000000000732

M3 - Article

C2 - 30418332

AN - SCOPUS:85056301729

VL - 38

SP - 494

EP - 501

JO - Journal of Neuro-Ophthalmology

JF - Journal of Neuro-Ophthalmology

SN - 1070-8022

IS - 4

ER -